STOCK TITAN

Cosmos Health Inc. (COSM) CFO swaps $60,000 debt for company stock

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Cosmos Health Inc. reported that Chief Financial Officer Georgios Terzis acquired 328,407 shares of common stock at $0.1827 per share. Under a Debt Exchange Agreement dated July 29, 2026, these Exchange Shares were issued in exchange for $60,000 of debt the company owed to him, bringing his direct holdings to 2,563,805 shares.

Positive

  • None.

Negative

  • None.
Insider Terzis Georgios
Role Chief Financial Officer
Type Security Shares Price Value
Grant/Award Common Stock, par value $.001 F1 328,407 $0.1827 $60K
Holdings After Transaction: Common Stock, par value $.001 — 2,563,805 shares (Direct)
Footnotes (1)
  1. F1. Pursuant to a debt exchange agreement by and between Georgios Terzis, the Company's CFO and the Company (the "Debt Exchange Agreement"), dated as of July 29, 2026, these shares are Exchange Shares (as defined in the Debt Exchange Agreement) being acquired by Mr. Terzis at the Exchange Rate (as defined in the Debt Exchange Agreement) of $0.1827 per share, the fair market value of the Common Stock on July 29, 2026, in exchange for a total amount of $60,000 in debt the Company owed to Mr. Terzis.
Shares acquired 328,407 shares Common stock received by CFO Georgios Terzis in the debt exchange
Exchange price $0.1827 per share Fair market value of common stock on July 29, 2026 used as Exchange Rate
Debt exchanged $60,000 Total amount of company debt to the CFO converted into Exchange Shares
Holdings after transaction 2,563,805 shares Total direct Cosmos Health common shares held by the CFO after the award
Debt Exchange Agreement financial
"Pursuant to a debt exchange agreement by and between Georgios Terzis..."
Exchange Shares financial
"these shares are Exchange Shares (as defined in the Debt Exchange Agreement)..."
fair market value financial
"the fair market value of the Common Stock on July 29, 2026..."
The price a willing buyer and a willing seller would agree on for an asset or security when neither is under pressure and both have access to the same information. Think of it as the market’s neutral estimate of what something is worth, like the price two neighbors would settle on for a car after comparing similar listings. Investors care because fair market value guides buying and selling decisions, tax reporting, portfolio valuation, and how accurately company assets are reflected in financial statements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Cosmos Health Inc. (COSM) disclose for its CFO?

Cosmos Health Inc. disclosed that CFO Georgios Terzis acquired 328,407 common shares at $0.1827 per share. The shares were received through a debt-for-equity exchange with the company.

How many Cosmos Health (COSM) shares does CFO Georgios Terzis hold after the transaction?

After the transaction, CFO Georgios Terzis directly holds 2,563,805 shares of Cosmos Health common stock. This figure includes the 328,407 Exchange Shares received in the reported debt exchange.

What was the value of debt exchanged for Cosmos Health (COSM) stock by the CFO?

CFO Georgios Terzis exchanged $60,000 of debt that Cosmos Health owed him for common stock. The debt was converted into 328,407 shares at a fair market value of $0.1827 per share.

At what price were the Exchange Shares issued to the Cosmos Health (COSM) CFO?

The Exchange Shares were issued at $0.1827 per share, described as the fair market value of Cosmos Health common stock on July 29, 2026. This rate determined the share count for the $60,000 debt exchange.

What is the Debt Exchange Agreement referenced in the Cosmos Health (COSM) Form 4?

The Debt Exchange Agreement is an arrangement between Georgios Terzis and Cosmos Health under which $60,000 of company debt to him was exchanged for 328,407 Exchange Shares at $0.1827 per share.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Terzis Georgios

(Last)(First)(Middle)
5 AG. GEORGIOU STR.

(Street)
PILEATHESSALONIKITK57001

(City)(State)(Zip)

GREECE

(Country)
2. Issuer Name and Ticker or Trading Symbol
Cosmos Health Inc. [ COSM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/29/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, par value $.00107/29/202607/29/2026A(1)328,407A$0.18272,563,805D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Pursuant to a debt exchange agreement by and between Georgios Terzis, the Company's CFO and the Company (the "Debt Exchange Agreement"), dated as of July 29, 2026, these shares are Exchange Shares (as defined in the Debt Exchange Agreement) being acquired by Mr. Terzis at the Exchange Rate (as defined in the Debt Exchange Agreement) of $0.1827 per share, the fair market value of the Common Stock on July 29, 2026, in exchange for a total amount of $60,000 in debt the Company owed to Mr. Terzis.
/s/ Georgios Terzis07/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)